OPPENHEIMER ASSET MANAGEMENT INC. - CONMED CORP ownership

CONMED CORP's ticker is and the CUSIP is 207410AF8. A total of 45 filers reported holding CONMED CORP in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
OPPENHEIMER ASSET MANAGEMENT INC. ownership history of CONMED CORP
ValueSharesWeighting
Q2 2023$184,560
+53.3%
120,000
+22.4%
0.00%
+50.0%
Q1 2023$120,393
+8.4%
98,0000.0%0.00%0.0%
Q4 2022$111,034
+5.7%
98,000
+2.1%
0.00%0.0%
Q3 2022$105,000
-13.2%
96,000
-4.0%
0.00%0.0%
Q2 2022$121,000
-34.9%
100,000
-7.4%
0.00%
-33.3%
Q1 2022$186,000
+1.6%
108,000
-1.8%
0.00%
+50.0%
Q4 2021$183,000
+0.5%
110,000
-6.8%
0.00%
-33.3%
Q3 2021$182,000
-7.6%
118,000
-3.3%
0.00%0.0%
Q2 2021$197,000
+28.8%
122,000
+24.5%
0.00%
+50.0%
Q1 2021$153,000
+12.5%
98,000
+1.0%
0.00%0.0%
Q4 2020$136,00097,0000.00%
Other shareholders
CONMED CORP shareholders Q1 2021
NameSharesValueWeighting ↓
Opti Capital Management, LP 44,065,000$71,296,0007.64%
Mohican Financial Management, LLC 3,000,000$4,878,0001.90%
SHENKMAN CAPITAL MANAGEMENT INC 9,398,000$15,357,0001.40%
OSTERWEIS CAPITAL MANAGEMENT INC 8,930,000$14,433,0000.74%
SSI INVESTMENT MANAGEMENT LLC 6,454,000$10,396,0000.67%
MACKAY SHIELDS LLC 38,286,000$61,845,0000.58%
PALISADE CAPITAL MANAGEMENT, LP 5,208,000$8,417,0000.19%
Calamos Advisors LLC 23,085,000$37,345,0000.17%
Polar Asset Management Partners Inc. 10,000,000$16,168,0000.17%
Calamos Wealth Management LLC 1,026,000$1,660,0000.13%
View complete list of CONMED CORP shareholders